Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
108.41
+1.14 (1.06%)
Nov 4, 2024, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 18,000 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
18,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$421,972
Profits / Employee
$60,194
Market Cap
21.58B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18,000 | 0 | - |
Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
Dec 31, 2021 | 19,500 | -500 | -2.50% |
Dec 31, 2020 | 20,000 | 100 | 0.50% |
Dec 31, 2019 | 19,900 | 900 | 4.74% |
Dec 31, 2018 | 19,000 | 800 | 4.40% |
Dec 31, 2017 | 18,200 | -300 | -1.62% |
Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
Dec 31, 2014 | 10,000 | 500 | 5.26% |
Dec 31, 2013 | 9,500 | 200 | 2.15% |
Dec 31, 2012 | 9,300 | 600 | 6.90% |
Dec 31, 2011 | 8,700 | -100 | -1.14% |
Dec 31, 2010 | 8,800 | 600 | 7.32% |
Dec 31, 2009 | 8,200 | -300 | -3.53% |
Dec 31, 2008 | 8,500 | 900 | 11.84% |
Dec 31, 2007 | 7,600 | 700 | 10.14% |
Dec 31, 2006 | 6,900 | 200 | 2.99% |
Dec 31, 2005 | 6,700 | 100 | 1.52% |
Dec 31, 2004 | 6,600 | 100 | 1.54% |
Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
Dec 31, 2002 | 3,600 | 200 | 5.88% |
Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Labcorp Holdings | 67,000 |
Teva Pharmaceutical | 37,851 |
STERIS | 18,179 |
The Cooper Companies | 15,000 |
Illumina | 13,360 |
West Pharmaceutical Services | 10,600 |
BeiGene | 10,600 |
Waters | 7,900 |
ZBH News
- 5 days ago - Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts - Benzinga
- 5 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Implant maker Zimmer Biomet lowers full-year profit forecast - Reuters
- 5 days ago - Zimmer Biomet Announces Third Quarter 2024 Financial Results - PRNewsWire
- 7 days ago - Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting - PRNewsWire
- 26 days ago - Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Large Joint Devices Market Size, Share, and Global Trends Analysis 2024-2030: Zimmer Biomet Leads Global Hip Reconstruction Market with Taperloc and Arcos Systems - GlobeNewsWire
- 4 weeks ago - Zimmer Biomet: The Undervalued Titan Of Joint Replacements - Seeking Alpha